Invictus MD’s Acreage Pharms Ltd. Receives Development Permit for Phase 2 and Provides Update

Invictus MD’s Acreage Pharms Ltd. Receives Development Permit for Phase 2 and Provides Update   FOREX INVESSTORS  PRESS RELEASE  Acreage Pharms Ltd   INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that its licensed production facility under the Access to Cannabis for Medical Purposes
Complete Reading

Invictus MD’s Executive Chairman Provides a Corporate Update BUZ INVESTORS  Corporate Update  INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) Canada’s Cannabis Company, is pleased to provide a corporate update on the back of its recently closed bought deal financing, and reprises its vision to expand and solidify its
Complete Reading

Canopy Growth Corporation Enters Into An Agreement with Invictus MD’s AB Laboratories For Cannabis Sales   BUZ INVESTORS  Canopy Growth Corporation  INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that AB Laboratories Inc. (“AB Labs”), a Licensed Producer under the Access to Cannabis for
Complete Reading

Invictus MD’s Future Harvest Achieves Increase In Gross Margin Benefiting From Its Focus On The Burgeoning Global Cannabis Sector      Invictus MD’s Future Harvest Achieves Increase  BUZ INVESTORS  Invictus MD’s Future Harvest Achieves Increase  INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) is pleased to report that
Complete Reading

Invictus MD’s Acreage Pharms Begins Cultivation with Commitment to Produce High Quality Cannabis   BUZ INVESTORS Invictus MD’s Acreage Pharms Begins Cultivation   INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (TSXV: IMH; OTC: IVITF; FRA: 8IS) announces that Acreage Pharms Ltd. (“Acreage Pharms”) which Invictus MD has the option to now acquire 100 percent
Complete Reading

Create Account



Log In Your Account